Daichi Utsumi Selected Research

Daichi Utsumi Research Topics

Disease

6	Colitis 06/2019 - 01/2016
4	Diarrhea 02/2024 - 05/2012
4	Body Weight (Weight, Body) 10/2021 - 05/2012
4	Inflammation (Inflammations) 03/2018 - 01/2016
3	COVID-19 01/2023 - 10/2021
2	Infections 01/2023 - 10/2021
2	Hypersensitivity (Allergy) 01/2022 - 10/2021
2	Acute Lung Injury 11/2021 - 10/2021
2	Neoplasms (Cancer) 01/2015 - 05/2012
2	Mucositis 01/2015 - 05/2012
1	Virus Diseases (Viral Diseases) 01/2023
1	Disease Progression 01/2023
1	Weight Loss (Weight Reduction) 11/2022
1	Asthma (Bronchial Asthma) 06/2022
1	Allergic Rhinitis 06/2022
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2022
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2022
1	Lung Injury 11/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Anaphylaxis (Anaphylactic Shock) 10/2021
1	Pain (Aches) 03/2018
1	Ileus 01/2018
1	Wounds and Injuries (Trauma) 09/2017

Drug/Important Bio-Agent (IBA)

5	Dextrans (Dextran)FDA Link 06/2019 - 01/2016
4	CytokinesIBA 02/2024 - 01/2015
3	AllergensIBA 06/2022 - 10/2021
3	SodiumIBA 01/2018 - 01/2016
2	ChemokinesIBA 10/2021 - 01/2017
2	Dextran SulfateIBA 06/2019 - 03/2018
2	CationsIBA 03/2018 - 01/2018
2	Substance PIBA 03/2018 - 01/2016
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2017 - 05/2012
2	Fluorouracil (Carac)FDA LinkGeneric 01/2015 - 05/2012
1	Immunoglobulins (Immunoglobulin)IBA 02/2024
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Alanine (L-Alanine)FDA Link 01/2023
1	Amino Acids FDA Link 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 11/2022
1	Dermatophagoides pteronyssinus antigen p 1IBA 06/2022
1	Pyridinolcarbamate (P23)IBA 06/2022
1	Immunoglobulin E (IgE)IBA 06/2022
1	Dermatophagoides pteronyssinus antigen p 2IBA 06/2022
1	CarboxypeptidasesIBA 11/2021
1	EnzymesIBA 11/2021
1	Angiotensin IIIBA 11/2021
1	AcidsIBA 11/2021
1	Angiotensin-Converting Enzyme 2IBA 11/2021
1	VaccinesIBA 10/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2021
1	Viral AntigensIBA 10/2021
1	bis(2- ((4- ((4'- (2- hydroxyethoxy)- 2'- methyl(1,1'- biphenyl)- 3- yl)methoxy)phenyl)methyl)- 3,5- dioxo- 1,2,4- oxadiazolidine)IBA 06/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2019
1	Calcitonin Gene-Related PeptideIBA 03/2018
1	Capsaicin (Zostrix)FDA Link 03/2018
1	AnkyrinsIBA 03/2018
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2018
1	cadherin 5IBA 01/2018
1	N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	Evans Blue (Blue, Evans)FDA Link 01/2018
1	LipopolysaccharidesIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	ColforsinIBA 09/2017
1	pamoic acidIBA 09/2017
1	Pertussis ToxinIBA 09/2017
1	Fibronectins (Fibronectin)IBA 09/2017
1	zaprinastIBA 09/2017
1	IntegrinsIBA 09/2017
1	Sulfonic AcidsIBA 01/2017
1	Peroxidase (Myeloperoxidase)IBA 01/2017
1	Ondansetron (Zofran)FDA LinkGeneric 01/2016
1	Serotonin (5 Hydroxytryptamine)IBA 01/2016
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2016
1	Aprepitant (Emend)FDA Link 01/2016
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2016
1	ramosetron (Nasea)IBA 01/2016
1	sairei-toIBA 01/2015

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
2	Immunotherapy 01/2022 - 10/2021
1	Oral Administration 02/2024
1	Extracorporeal Membrane Oxygenation 01/2023
1	Therapeutics 10/2021
1	Injections 09/2017
1	Kampo Medicine (Kampo) 01/2015